Quantcast

Latest Frederic Chereau Stories

2014-02-05 08:29:22

Strategic Business Leader Brings Complementary Product Commercialization and Rare Disease Expertise SAN DIEGO, Feb. 5, 2014 /PRNewswire/ -- aTyr Pharma ("aTyr"), an innovative biotherapeutics enterprise, announced today that Frederic Chereau has joined aTyr as president and chief operating officer. Mr. Chereau has more than 20 years of experience in bringing new rare disease products to market and has held key leadership positions at Shire and Genzyme. Mr. Chereau's appointment will...

2010-10-28 07:00:00

CAMBRIDGE, Mass., Oct. 28 /PRNewswire/ -- Pervasis Therapeutics, Inc. today announced that Frederic Chereau, president and chief executive officer of the company, is among the recipients of Mass High Tech's 2010 All-Stars Awards, which recognize 16 dynamic and influential leaders of New England's innovation economy. Pervasis is a clinical stage company focused on developing breakthrough therapies with the potential to improve outcomes following common vascular surgical and interventional...

2008-10-21 06:00:24

Pervasis Therapeutics, Inc., a biotechnology company pioneering biologically active therapies and devices to treat serious illnesses, today announced that Frederic Chereau has been named the Company's president and chief executive officer. Mr. Chereau was formerly the vice president and general manager of Genzyme Cardiovascular (CV), a business unit within Genzyme Corporation in Cambridge. Under Mr. Chereau's leadership, Genzyme CV expanded its cell and gene therapy programs, as well as...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'